Viridian Therapeutic (VRDN) PT Raised to $40 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts VRDN Hot Sheet
Price: $22.08 --0%
Rating Summary:
16 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 17
Rating Summary:
16 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 17
Join SI Premium – FREE
H.C. Wainwright analyst Douglas Tsao raised the price target on Viridian Therapeutic (NASDAQ: VRDN) to $40.00 (from $35.00) while maintaining a Buy rating.
You May Also Be Interested In
- AEON Biopharma, Inc (AEON) PT Lowered to $1.20 at H.C. Wainwright
- JBS SA (JBS) PT Lowered to $17 at Stephens
- Intuit (INTU) PT Lowered to $430 at Mizuho
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
